8.63
price up icon1.95%   0.165
pre-market  Pre-mercato:  8.65   0.02   +0.23%
loading
Precedente Chiudi:
$8.465
Aprire:
$8.44
Volume 24 ore:
1.38M
Relative Volume:
1.22
Capitalizzazione di mercato:
$832.71M
Reddito:
-
Utile/perdita netta:
$-106.81M
Rapporto P/E:
-2.6059
EPS:
-3.3117
Flusso di cassa netto:
$-8.40M
1 W Prestazione:
-0.58%
1M Prestazione:
-4.75%
6M Prestazione:
-18.04%
1 anno Prestazione:
-26.24%
Intervallo 1D:
Value
$8.35
$8.99
Intervallo di 1 settimana:
Value
$8.35
$9.3423
Portata 52W:
Value
$5.1501
$16.81

Immunome Inc Stock (IMNM) Company Profile

Name
Nome
Immunome Inc
Name
Telefono
610-321-3700
Name
Indirizzo
18702 N. CREEK PARKWAY, BOTHELL
Name
Dipendente
131
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IMNM's Discussions on Twitter

Confronta IMNM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IMNM
Immunome Inc
8.63 832.71M 0 -106.81M -8.40M -3.3117
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Immunome Inc Stock (IMNM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-02 Iniziato Lake Street Buy
2024-11-08 Iniziato Stephens Overweight
2024-05-31 Iniziato Piper Sandler Overweight
2024-04-30 Iniziato JP Morgan Overweight
2024-04-15 Iniziato Guggenheim Buy
2024-01-29 Iniziato Leerink Partners Outperform
2023-12-19 Iniziato Wedbush Outperform
2021-10-29 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Immunome Inc Borsa (IMNM) Ultime notizie

pulisher
Jun 16, 2025

Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 15, 2025

Trend Tracker for (IMNM) - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Immunome, Inc. (NASDAQ:IMNM) Stake Raised by Wealth Enhancement Advisory Services LLC - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High? - sharewise

Jun 12, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 14,328 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Sells 44,020 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Immunome Elects New Directors at Annual Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Reduces Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Sold by Jane Street Group LLC - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 5, 2025 - BioSpace

Jun 06, 2025
pulisher
Jun 06, 2025

Lifesci Capital Has Bullish Outlook for Immunome Q2 Earnings - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunome Reports Inducement Grants Under Nasdaq Listing Rule - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Makes New $512,000 Investment in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Jun 04, 2025
pulisher
Jun 03, 2025

14,477 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Purchases Shares of 154,467 Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Buys New Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Invests $70,000 in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Jun 03, 2025
pulisher
May 30, 2025

Deutsche Bank AG Has $489,000 Stock Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

May 30, 2025
pulisher
May 27, 2025

Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet - MSN

May 27, 2025
pulisher
May 25, 2025

Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

(IMNM) Trading Report - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Immunome to Present at Upcoming Investor Conferences - BioSpace

May 22, 2025
pulisher
May 22, 2025

Cancer Therapy Developer Immunome Set for TD Cowen and Goldman Sachs Healthcare Conferences - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 20, 2025

Immunome, Inc. Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 20, 2025

Immunome stock rating cut to Hold by Boral Capital - Investing.com Nigeria

May 20, 2025
pulisher
May 17, 2025

Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 17, 2025
pulisher
May 16, 2025

Leerink Partnrs Has Strong Estimate for Immunome Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Voya Investment Management LLC Has $166,000 Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

May 15, 2025
pulisher
May 15, 2025

All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy - MSN

May 15, 2025
pulisher
May 14, 2025

Immunome (NASDAQ:IMNM) Shares Gap Up Following Earnings Beat - Defense World

May 14, 2025
pulisher
May 14, 2025

Immunome First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Immunome (IMNM) Financial Update and Clinical Progress in Q1 202 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Wedbush Adjusts Price Target on Immunome to $21 From $33, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

(IMNM) Investment Report - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace

May 12, 2025
pulisher
May 12, 2025

Immunome Inc (IMNM) Q1 2025 Earnings: EPS Loss of $0.52 Beats Es - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Immunome Q1 Income From Operations USD -44.636 Million - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Immunome Expands Share Reserve in Inducement Plan - TipRanks

May 12, 2025
pulisher
May 12, 2025

Immunome Reports First Quarter 2025 Financial Results and Provides Business Update | IMNM Stock News - GuruFocus

May 12, 2025

Immunome Inc Azioni (IMNM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Immunome Inc Azioni (IMNM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Higgins Jack
Chief Scientific Officer
Mar 27 '25
Option Exercise
1.35
5,200
7,020
18,729
BIENAIME JEAN JACQUES
Director
Mar 25 '25
Buy
7.78
7,800
60,684
31,415
SIEGALL CLAY B
President and CEO
Mar 26 '25
Buy
7.29
137,100
999,459
806,736
BIENAIME JEAN JACQUES
Director
Mar 24 '25
Buy
8.21
7,000
57,470
23,615
Tsai Philip
Chief Technology Officer
Mar 24 '25
Buy
8.42
12,300
103,566
33,300
SIEGALL CLAY B
President and CEO
Jan 31 '25
Buy
7.75
150,000
1,162,500
669,636
SIEGALL CLAY B
President and CEO
Nov 21 '24
Buy
9.54
66,057
630,263
485,693
SIEGALL CLAY B
President and CEO
Nov 22 '24
Buy
9.78
33,943
331,918
519,636
Lechleider Robert
Chief Medical Officer
Nov 21 '24
Buy
9.48
15,805
149,800
15,805
Tsai Philip
Chief Technology Officer
Nov 21 '24
Buy
9.43
21,000
198,030
21,000
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):